Evaluation of the Application Status Quo of Blockchain Technology in China ’s Pharmaceutical Field
返回论文页
|更新时间:2022-06-21
|
Evaluation of the Application Status Quo of Blockchain Technology in China ’s Pharmaceutical Field
China PharmacyVol. 31, Issue 17, (2020)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2020,
扫 描 看 全 文
YANG Chunsong, ZHANG Lingli, GAO Shan, et al. Evaluation of the Application Status Quo of Blockchain Technology in China ’s Pharmaceutical Field. [J]. China Pharmacy 31(17).(2020)
DOI:
YANG Chunsong, ZHANG Lingli, GAO Shan, et al. Evaluation of the Application Status Quo of Blockchain Technology in China ’s Pharmaceutical Field. [J]. China Pharmacy 31(17).(2020)DOI:
Evaluation of the Application Status Quo of Blockchain Technology in China ’s Pharmaceutical Field
OBJECTIVE:To evaluate t he c urrent status of the application of blockchain technology in China ’s pharmaceutical field,and to provide direction and decision support for its wide application and development in the domestic pharmaceutical field. METHODS:Retrieved from Embase ,PubMed,Cochrane library ,CBM,CNKI,VIP and Wanfang databases during the inception of databases to Sept. 30th,2019,the studies on application status of blockchain technology in China ’s pharmaceutical field were collected;descriptive analysis was conducted for research type ,publication time ,main research fields and existing problems. RESULTS & CONCLUSIONS :A total of 60 literatures were included ,and all of them were Chinese literatures. Among them ,38 literatures were reviews ,19 were original researches ,2 were dissertation ,1 was conference paper. The publication time range was from 2016 to 2019. The application of blockchain technology in the main pharmaceutical fields is to promote the sharing of electronic medical record data ,personal health data ,clinical research data and genomic data ;the traceable path is mainly provided in medical insurance audits ,drug quality traceability and anti-counterfeiting ,medical devices and medical supplies traceability. These applications are still in the preliminary theoretical verification or trial stage. At present ,there are still some limitations or problems in the relevant policies and application standards ,data storage space and processing ,data privacy and security ,and professionals in China ’s pharmaceutical field. However ,it has high application value and potential in medical data sharing , reducing treatment costs , improving medical claim system , strengthening medical management and optimizing medical decision-making.